期刊文献+

中西医结合治疗胃肠道肿瘤临床研究 被引量:5

Clinical Research of Combined Traditional Chinese and Western Medicine in the Treatment of Gastroenteric Tumor
下载PDF
导出
摘要 目的:探讨中西医结合治疗胃肠道肿瘤的临床疗效。方法:选取2012年1月至2013年1月的60例胃肠道肿瘤患者为研究对象,按随机数字表法分为观察组和对照组,每组各30例。对照组实施伊立替康和5-氟尿嘧啶联合治疗,观察组在对照组治疗的基础上配合参苓白术散加减治疗。结果:两组患者近期临床疗效比较,差异无统计学意义(P>0.05)。观察组患者的生命质量远远好于对照组,差异具有统计学意义(P<0.05)。结论:对于患者胃肠道肿瘤的治疗,采用西医治疗并结合参苓白术散的加减使用可以使患者的抵抗力得到提高,使患者在放疗、化疗之后的不良反应减少,生活质量得到提高,患者的生存期得到延长。 Objective:To study the clinical curative effect of combined traditional Chinese and western medicine treatment in treating gastrointestinal tumors.Methods:Choose 60 cases with gastrointestinal cancer from January 2012 to January 2013 as the research object.60 cases were divided into observation group and control group according to randomization principle,30 cases in each group.The control group was given Litikang and 5-fluorouracil combination and the observation group was given flavored ShenlingBaizhuSan based on the control group.Compare and observe the recent clinical curative effect of observation group and control group.There was no statistically significant difference(P0.05).But the life quality in observation group was far better than that in control group.The difference is statistically significant(P0.05).Conclusion:Use western medicine combined with flavored ShenglingBaizhuSan in the treatment of gastrointestinal tumor can improve resistance of patients and life quality,reduce he adverse reaction after chemotherapy and prolong life span of patients.It deserves generalization in clinical application.
作者 刘华汉
机构地区 灵山县中医医院
出处 《中医学报》 CAS 2013年第7期937-938,共2页 Acta Chinese Medicine
基金 广西中医药管理局科研计划项目(编号:2011026)
关键词 胃肠道肿瘤 中西医结合 参苓白术散 伊立替康 5-氟尿嘧啶 gastrointestinal tumor combined treatment of traditional Chinese and western medicine Shenling Baizhu San li tikang 5-fluorouracil
  • 相关文献

参考文献8

二级参考文献25

共引文献53

同被引文献35

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部